Opening a can of worms in AL progression

Angela Dispenzieri

doi:10.1182/blood-2017-11-815423

Opening a can of worms in AL progression

Angela Dispenzieri

Hematology

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

In this issue of Blood, Palladini et al address one of the most important, yet befuddling questions in immunoglobulin light chain (AL) amyloidosis treatment: what triggers should be used to reinstitute plasma cell clone directed therapy among patients with AL amyloidosis?.

Original language	English (US)
Pages (from-to)	475-476
Number of pages	2
Journal	Blood
Volume	131
Issue number	5
DOIs	https://doi.org/10.1182/blood-2017-11-815423
State	Published - Feb 1 2018

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2017-11-815423

Cite this

@article{141dd10833c648048fc3861369926a62,

title = "Opening a can of worms in AL progression",

abstract = "In this issue of Blood, Palladini et al address one of the most important, yet befuddling questions in immunoglobulin light chain (AL) amyloidosis treatment: what triggers should be used to reinstitute plasma cell clone directed therapy among patients with AL amyloidosis?.",

author = "Angela Dispenzieri",

note = "Publisher Copyright: {\textcopyright} 2018 by The American Society of Hematology.",

year = "2018",

month = feb,

day = "1",

doi = "10.1182/blood-2017-11-815423",

language = "English (US)",

volume = "131",

pages = "475--476",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "5",

}

TY - JOUR

T1 - Opening a can of worms in AL progression

AU - Dispenzieri, Angela

PY - 2018/2/1

Y1 - 2018/2/1

N2 - In this issue of Blood, Palladini et al address one of the most important, yet befuddling questions in immunoglobulin light chain (AL) amyloidosis treatment: what triggers should be used to reinstitute plasma cell clone directed therapy among patients with AL amyloidosis?.

AB - In this issue of Blood, Palladini et al address one of the most important, yet befuddling questions in immunoglobulin light chain (AL) amyloidosis treatment: what triggers should be used to reinstitute plasma cell clone directed therapy among patients with AL amyloidosis?.

UR - http://www.scopus.com/inward/record.url?scp=85041342788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041342788&partnerID=8YFLogxK

U2 - 10.1182/blood-2017-11-815423

DO - 10.1182/blood-2017-11-815423

M3 - Review article

C2 - 29437606

AN - SCOPUS:85041342788

SN - 0006-4971

VL - 131

SP - 475

EP - 476

JO - Blood

JF - Blood

IS - 5

ER -

Opening a can of worms in AL progression

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this